Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$225.49
+1.5%
$209.20
$151.61
$242.52
$2.39T1.3342.00 million shs22.94 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$83.26
-2.6%
$84.31
$57.52
$117.19
$32.69B1.444.41 million shs469,148 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amazon.com, Inc. stock logo
AMZN
Amazon.com
-0.13%-0.39%+2.14%+20.23%+11.25%
DexCom, Inc. stock logo
DXCM
DexCom
+0.70%+3.30%+0.75%+29.21%-22.86%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amazon.com, Inc. stock logo
AMZN
Amazon.com
4.6008 of 5 stars
3.53.00.03.02.72.51.9
DexCom, Inc. stock logo
DXCM
DexCom
4.8812 of 5 stars
3.55.00.04.72.42.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amazon.com, Inc. stock logo
AMZN
Amazon.com
3.00
Buy$248.6310.26% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.95
Moderate Buy$98.5018.30% Upside

Current Analyst Ratings Breakdown

Latest DXCM and AMZN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/11/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight$240.00 ➝ $255.00
7/10/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform
7/10/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$250.00 ➝ $300.00
7/10/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Citizens Jmp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageStrong-Buy
7/10/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$250.00 ➝ $285.00
7/10/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$235.00
7/8/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$215.00 ➝ $250.00
7/8/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$201.00 ➝ $238.00
7/2/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$226.00 ➝ $250.00
7/1/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperform ➝ Outperform$235.00
6/16/2025
DexCom, Inc. stock logo
DXCM
DexCom
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$102.00
(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$637.96B3.75$10.71 per share21.05$26.98 per share8.36
DexCom, Inc. stock logo
DXCM
DexCom
$4.15B7.87$2.21 per share37.76$5.38 per share15.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$59.25B$6.1436.7430.311.6710.14%24.14%10.90%7/30/2025 (Estimated)
DexCom, Inc. stock logo
DXCM
DexCom
$576.20M$1.3462.2133.851.8112.90%30.05%10.00%7/30/2025 (Estimated)

Latest DXCM and AMZN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$1.31N/AN/AN/A$161.80 billionN/A
7/30/2025Q2 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.45N/AN/AN/A$1.13 billionN/A
5/1/2025Q1 2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$1.38$1.59+$0.21$1.59$154.96 billion$155.67 billion
5/1/2025Q1 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.33$0.32-$0.01$0.27$1.02 billion$1.04 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amazon.com, Inc. stock logo
AMZN
Amazon.com
N/AN/AN/AN/AN/A
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amazon.com, Inc. stock logo
AMZN
Amazon.com
0.17
1.05
0.84
DexCom, Inc. stock logo
DXCM
DexCom
0.55
1.50
1.32

Institutional Ownership

CompanyInstitutional Ownership
Amazon.com, Inc. stock logo
AMZN
Amazon.com
72.20%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%

Insider Ownership

CompanyInsider Ownership
Amazon.com, Inc. stock logo
AMZN
Amazon.com
9.70%
DexCom, Inc. stock logo
DXCM
DexCom
0.32%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amazon.com, Inc. stock logo
AMZN
Amazon.com
1,556,00010.62 billion9.59 billionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
10,300392.11 million390.85 millionOptionable

Recent News About These Companies

DexCom, Inc. (NASDAQ:DXCM) Shares Sold by Lbp Am Sa

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amazon.com stock logo

Amazon.com NASDAQ:AMZN

$225.48 +3.23 (+1.45%)
As of 11:53 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. Amazon.com, Inc. was incorporated in 1994 and is headquartered in Seattle, Washington.

DexCom stock logo

DexCom NASDAQ:DXCM

$83.26 -2.20 (-2.57%)
As of 11:53 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.